Veracyte (VCYT) Net Cash Flow (2012 - 2026)

Veracyte has disclosed Net Cash Flow across 15 years of filings, most recently posting -$99.4 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$99.4 million, down 87.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.4 million (up 443.35% YoY), and the FY2025 annual result was $122.9 million, up 417.92% from the prior year.
• Net Cash Flow came in at -$99.4 million for Q1 2026 at Veracyte, down from $47.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $96.0 million in Q3 2025 to a low of -$99.4 million in Q1 2026.
• The 5-year median for Net Cash Flow is $13.4 million (2023), against an average of $5.4 million.
• Across the five-year window, Net Cash Flow soared 352.74% in 2023 and plunged 661.51% in 2025, its largest moves.
• Veracyte's Net Cash Flow stood at -$16.6 million in 2022, then jumped by 182.55% to $13.7 million in 2023, then sank by 349.1% to -$34.1 million in 2024, then soared by 237.73% to $47.0 million in 2025, then sank by 311.42% to -$99.4 million in 2026.
• The last three Net Cash Flow figures came in at -$99.4 million (Q1 2026), $47.0 million (Q4 2025), and $96.0 million (Q3 2025), per Business Quant data.